Mar 02, 2021 / 05:50PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
And good afternoon, everybody, and thank you for joining us for the second day of the 41st Annual Cowen Healthcare Conference. I'm Yaron Werber, biotech analyst here at Cowen with my colleague, Brendan Smith. And it's a great pleasure for us to moderate the fireside chat with FibroGen.
Today, we have Enrique Conterno, who's the CEO; and Mike Tung, VP of Investor Relations and Strategy. Gentlemen, thanks so much for joining us. We appreciate it.
Enrique A. Conterno - FibroGen, Inc. - CEO & Director
Thank you very much for the invitation, Yaron.
Questions and Answers:
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology AnalystAbsolutely. So Enrique, maybe the timing for this is good in a way, just given some of the news from yesterday, obviously, wasn't prepped that way by chance. But maybe give us a little bit of a sense related to the news flow